How Big Pharma’s China Trials Are Escaping Scrutiny
U.S. supply chains with connections to Xinjiang and the Chinese military are heavily regulated — just not for pharmaceuticals.
Showing 157 - 168 of 1880
China’s Connected Vehicles Widen the U.S.-Canada Disconnect
A Chinese EV maker that is expanding in Canada has ties to a U.S.-sanctioned surveillance company, illustrating the data and security risks connected vehicles pose.
Eleven days on Hainan, Part II
Plus, sunny days for China’s solar industry in Africa.
Michael Luo on the Story of Chinese Immigrants in the U.S.
The writer and editor talks about the first arrivals from China and the long history of prejudice the community has faced.
Eleven Days, Part II
To mark the 25th anniversary of the Hainan spy plane crisis, The Wire China is publishing the second installment of its discussions with people who...
China’s Solar Industry Follows the Sun to Africa
Chinese solar firms are exporting far more to Africa as their U.S. and European markets fade. That could make the Sino-African trade relationship even more...
Why China Should Boost its Lending To Developing Countries
China's retreat from lending to developing countries has come at precisely the wrong time for the global economy.
Pharma Bets Big on Chinese Drugmakers
Despite regulatory obstacles, big pharma is so confident in China’s R&D they’re purchasing the rights to medicines that don’t yet exist.
Neil Shearing on Living Through the Fractured Age
The economist talks about the world economy’s break down into two blocs, and whether the U.S. or China hold the advantage.
Eleven Days, Part I
On the eve of the 25th anniversary of the Hainan spy plane crisis, The Wire China talks with participants and reviews first-person accounts of the...
The Hainan Spy Plane Crisis, an Oral History
Also, OpenClaw grips China.
Company in the News: XPeng
The EV giant is hoping AI-driven systems for cars and robots will help drive profits.